Definitive agreement to acquire Core Scientific
Company: CoreWeave
The claim, verbatim
CoreWeave signed a definitive agreement to acquire Core Scientific in an all-stock transaction at a fixed exchange ratio of 0.1235 CoreWeave Class A shares per Core Scientific share, implying a total equity value of about $9.0 billion as of July 3, 2025, a premium of about 66% to Core Scientific's unaffected share price.
Source (primary)
coreweave 8-K exhibit (dp231291_ex9901.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-11)Live source ↗
Quote: “As of July 3, 2025, the agreed-upon exchange ratio implies a total equity value of approximately $9.0 billion.”
How we checked this
Checked on October 15, 2026. The cited source supports every part of this claim.
The press release states the definitive all-stock agreement, the 0.1235 fixed exchange ratio, the roughly $9.0 billion implied equity value as of July 3, 2025, and the roughly 66% premium to the unaffected price.
Confirmed in the source:
- CoreWeave signed a definitive agreement to acquire Core Scientific
- The deal is an all-stock transaction
- The exchange ratio is fixed at 0.1235 CoreWeave Class A shares per Core Scientific share
- The exchange ratio implied a total equity value of approximately $9.0 billion as of July 3, 2025
- The deal represented a premium of approximately 66% to Core Scientific's unaffected share price of $12.30 on June 25, 2025
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1769628/000095010325008492/dp231291_ex9901.htm) in full (19,372 characters, retrieved October 11, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms coreweave 8-K exhibit (dp231291_ex9901.htm)
Quote: “As of July 3, 2025, the agreed-upon exchange ratio implies a total equity value of approximately $9.0 billion.”